key: cord-0023178-tytiexwn
authors: Sheikhi Moghaddam, Laleh; Adegbite, Ayobami; McCarthy, Pumtiwitt C.
title: Investigation of bioluminescence-based assays for determination of kinetic parameters for the bifunctional Neisseria meningitidis serogroup W capsule polymerase
date: 2021-11-18
journal: BMC Res Notes
DOI: 10.1186/s13104-021-05831-1
sha: 73464805d0476dc495b6e0e7a2a85ce3be4c1c51
doc_id: 23178
cord_uid: tytiexwn

OBJECTIVE: Neisseria meningitidis is a Gram-negative bacterium that causes meningitis. N. meningitidis serogroup W (NmW) capsule polymerase synthesizes capsular polysaccharide of this serogroup. This enzyme could be a tool for meningococcal glycoconjugate vaccine development. Our long-term goal is to control activity of the NmW capsule polymerase for production of defined carbohydrates for vaccines. The enzyme lacks a simple, high-throughput activity assay. Here, we describe the use of high-throughput bioluminescence assays (CMP-Glo and UDP-Glo by Promega) to investigate NmW capsule polymerase activity. These assays detect free nucleotides produced during transfer of sugar from UDP-Galactose and CMP-Sialic Acid to an acceptor. Kinetic studies using NmW hydrolyzed polysaccharide (PS) acceptor are described as well as preliminary work with a sialic acid trimer (DP3) acceptor. RESULTS: In CMP-Glo kinetic studies, with constant donor (80 µM) and varied NmW hydrolyzed polysaccharide (0–2000 µg/mL), a K(m) of 629.2 ± 101.4 µg/mL and a V(max) of 0.8965 ± 0.05823 µM/min was obtained. Using UDP-Glo, K(m) and V(max) values of 13.84 ± 9.675 µM and 0.6205 ± 0.1331 µM/min were obtained with varied CMP-NeuNAc (0–80 µM) and constant acceptor (400 µg/mL) and UDP-Gal (80 µM). This is the first report of using bioluminescence assays for NmW kinetics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-021-05831-1.

Neisseria meningitidis is a gram-negative bacterium that causes most cases of bacterial meningitis [1] . Of the 13 serogroups of the bacteria, there are six to which disease is attributed [1] [2] [3] . Each serogroup is defined by its capsular polysaccharides. The capsule polymerase enzymes, responsible for biosynthesis of capsular polysaccharides, from the six pathogenic serogroups (A, B, C, W, Y and X) have been characterized to varying degrees [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Our current focus is the Neisseria meningitidis serogroup W (NmW) capsule polymerase enzyme. This bifunctional enzyme transfers sialic acid and galactose from two nucleotide donor substrates (CMP-Neu5Ac and UDP-Gal) to an acceptor during synthesis of capsular polysaccharide. The long-term goal is to gain insight into the NmW capsule polymerase as a tool for controlled synthesis of carbohydrates for use in glycoconjugate vaccines [16] . Glycoconjugate vaccines with defined carbohydrate length and well-characterized attachment to carrier proteins will be key to maximizing vaccine efficacy [17] .

There are no assays described in the current NmW capsule polymerase literature that allow for determination of the kinetic parameters of the enzyme in a simple Sheikhi Moghaddam et al. BMC Research Notes (2021) 14:417 high-throughput manner using unlabeled acceptors. At the time we began this work in 2018, the only report of kinetics was our previous work which used a continuous, absorbance-based assay with unlabeled acceptors [18] . In 2020, the Chen lab published elegant work using one-pot multienzyme synthesis (OPME) of chromophore-labelled oligosaccharides to determine kinetics in an HPLC-based assay [8] . In this work, we investigate commercially available bioluminescence-based assays (CMP-Glo and UDP-Glo) as tools to determine kinetics of the NmW capsule polymerase. We selected these kits for their high-throughput 96-well format, sensitivity and the ability to use unlabeled acceptors. These kits detect free UDP and CMP produced by glycosyl transfer [19] [20] [21] (Additional file 1: Fig. S1 ). UDP-Glo or CMP-Glo nucleotide detection reagents (NDR, each containing a proprietary luciferase) are added to sample on the 96 well plates to quench the glycosyltransferase reaction. Any free CMP or UDP present is converted to ATP and luminescence is produced and monitored. Thus, increased luminescence correlates with increased ATP which correlates with more glycosyltransferase activity. Here we describe our initial efforts to obtain kinetics using both kits and lessons learned from adapting these assays for the bifunctional NmW capsule polymerase.

The enzyme was recombinantly overexpressed in E. coli KRX cells, purified and characterized according to a published procedure [18] .

To determine optimal amounts of enzyme to use, assays were performed with different amounts of purified serogroup W enzyme (0 as a control, 50, 125, 250, 500, 750, 1000, and 1250 ng for reaction), CMP-NeuNAc (80 µM), UDP-Gal (80 µM), DTT (100 µM each), hydrolyzed serogroup W Acceptor (400 µg/mL), in a buffer (50 mM Tris, 20 mM MgCl 2 , 2 mM DTT, pH 8.0) established in the literature [4, 5, 18] . Reactions were run for 1 h at room temperature (RT) in 96-well plates with shaking to mix and quenched by adding CMP-Glo NDR. Luminescence was monitored on a Promega GloMax Navigator. All other CMP-Glo experiments were performed as described except with these modifications: to determine the optimal nucleotide donor concentrations-50 ng of enzyme was used, CMP-NeuNAc and UDP-Gal were varied (0-100 µM); To determine activity effects of removing one component-either NmW enzyme, acceptor, CMP-NeuNAc or UDP-Gal was absent; Time quench experiments-NmW enzyme (50 ng) was absent or present and quenched after 1, 5, 10,15, and 20 min; Kinetic studieseither acceptor was varied (0-2000 µg/mL acceptor) or CMP-NeuNAc (0-80 µM); reactions were quenched after 10 min. For all bioluminescence studies, GraphPad Prism 8.0 software was used to graph and analyze results.

All studies performed with the UDP-Glo kit and reagents were done in a similar manner as described for CMP-Glo except as described. Specific modifications were the use of 1250 ng of NmW capsule polymerase in experiments to determine activity effects of removing one component and in time quenching experiments. In reactions using DP3 as an acceptor, 2 mM was used except in studies to determine optimal acceptor concentration (0-4 mM DP3 acceptor was used).

Hydrolyzed W capsular polysaccharide (10 mg/mL) was prepared as described previously [18] . The hydrolyzed NmW capsular polysaccharide was labeled with DMB according to a published procedure [22] to give a final concentration of 5 mg/mL hydrolyzed sugar. Activity was tested by reaction with NmW capsule polymerase with DMB-labelled hydrolyzed W polysaccharide (0.25 mg/ mL), DTT (2 mM) in the presence or absence of 2 mM CMP-NeuNAc and 2 mM UDP-Gal respectively in the same buffer used in other studies. Control reactions contained no enzyme. Fluorescence detection was checked by HPLC using previously described conditions [7, 23] after 15 h incubation at 37 ºC. GraphPad Prism 8.0 was used to graph chromatogram results.

The long-term goal of this research is to control activity of the NmW capsule polymerase for production of welldefined carbohydrates for glycoconjugate vaccines. This work describes the application of facile, high-throughput assay methods to advance this goal. Results described here are the culmination of 55 individual experiments in which two or three replicates were performed.

In efforts to determine the optimal conditions to perform the enzyme reactions using these kits, a series of reactions (containing CMP-NeuNAc, UDP-Gal, DTT, hydrolyzed serogroup W polysaccharide acceptor, with or without enzyme) were performed in which the only component varied was the amount of enzyme. The results for the UDP-Glo assay (Additional file 2: Fig. S2A ) show increase in activity as the amount of enzyme increases (max. with 1000 ng). The results for the CMP-Glo assay (Additional file 2: Fig. S2B ), a measure of sialyltransferase activity, indicate a bell-shaped activity curve (max. with 50 ng). This was an unexpected result as it was assumed that the same enzyme concentration would be used for both assay kits. However, these results suggested that the activities of the two catalytic domains were not tightly correlated under these conditions. Nevertheless, the enzyme amount selected for further studies using the CMP-Glo assay was 50 ng. vs. 750 ng of enzyme to be used in the UDP-Glo assay because the luminescence output was comparable.

With knowledge of how much serogroup W enzyme to use, both the optimal amount of nucleotide donors and the linearity of the enzyme reaction were investigated. The optimal amount of luminescence was obtained with 80 µM CMP-NeuNAc and UDP-Gal in both kits. In addition, the enzymatic reactions were found to be linear over 10 min (Additional file 3: Fig. S3) . Initially, kinetic measurements used only the CMP-Glo assay. For all kinetic assays, one component (either UDP-Gal, CMP-NeuNAc or hydrolyzed acceptor) was varied while all other components were held constant. When both nucleotide donor sugars were constant (at 80 µM each) and the amount of hydrolyzed serogroup W acceptor was varied (0-2000 µg/mL), a K m value of 629.2 ± 101.4 µg/mL and a V max of 0.8965 ± 0.05823 µM/min (Fig. 1A) were obtained. In kinetic studies with varied CMP-NeuNAc (0-80 µM) and constant acceptor, a K m and V max values were obtained 13.84 ± 9.675 µM and 0.6205 ± 0.1331 µM/ min (Fig. 1B) . This data set showed more variability as evidenced by the error bars and reduced R 2 value. The related standard curves show the data is reliable (R 2 > 0.95) (Fig. 1C, D) .

Because of the continued variability in the data, further confirmation that the change in luminescence observed was enzyme-mediated was needed. A series of reactions in the absence of selected components was performed using both bioluminescence kits. Galactosyltransferase activity (as observed using UDP-Glo) was seen only in the presence of all components as expected ( Fig. 2A) .

The results of monitoring sialyltransferase activity (using CMP-Glo) were unexpected. There was an enzymemediated increase in activity in the absence of UDP-Gal (Fig. 2B ). To gain more understanding into this finding, the products of enzymatic elongation of DMBlabeled hydrolyzed acceptor by the serogroup W capsule polymerase was visualized by anion exchange HPLC-FD. The goal was to observe whether there was any change in the chromatogram in the presence of the capsule polymerase, acceptor and with no UDP-Gal present or with no CMP-NeuNAc. As reported previously by Romanow et al., there are signature peak retention time shifts observed in elongated fluorescent products [4] . Decreased retention time indicates addition of galactose (due to the decrease in polarity by addition of the neutral sugar) and increased retention time indicates addition of sialic acid. Our data suggests that the hydrolyzed acceptor being used was primarily galactosylated (Fig. 2C,  D) . In the absence of CMP-NeuNAc and the presence of UDP-Gal, there is only a shift of one peak, and this is towards decreased retention time. In contrast, when CMP-NeuNAc is included and UDP-Gal omitted, there is a shift of nearly all remaining peaks towards increased retention time suggesting sialylation. At this point, it was unclear whether there was preferential hydrolysis of the polysaccharide or whether there was preferential labeling during incubation with DMB [22] . The DMB dye will only label free reducing end sialic acids so this phenomenon may influence the products that are visualized. We transitioned to a well-defined oligosaccharide which is a known substrate of the enzyme: a trimer of α, 2-8 linked sialic acid [4, 5] .

While the UDP-Glo kit includes commercially available ultrapure UDP-Gal (essential in avoiding high background rates) there is no commercially available ultrapure CMP-NeuNAc. Our source of CMP-NeuNAc was the highest purity commercially available, [guaranteed 97% by Nacalai-Tesque and verified by HPLC analysis (not shown)] yet this seemingly small 3% impurity was having a large effect on results because of the sensitivity of the assay. To circumvent this, CMP-NeuNAc solutions were pre-treated with alkaline phosphatase (AP) (Additional file 4: Fig. S4A , Additional file 5). This enzyme removes phosphoryl groups from nucleotide mono-and diphosphates [24] . There were decreased levels of background CMP after this pre-treatment. DP3 trimer was also subjected to AP treatment with no change observed (Additional file 4: Fig. S4B ). Despite this, there was still a considerable amount of unexplainable background luminescence (results not shown). The decision was made to focus solely on the UDP-Glo assay for subsequent studies with DP3 acceptor and continue AP pre-treatment of CMP-NeuNAc because better luminescence was observed (Additional file 6: Fig. S5A, B) .

Similar optimization assays were performed with sialic acid trimer using the UDP-Glo system. The trends mirrored those observed with hydrolyzed acceptor. Namely, there was an increase in activity with increasing levels of enzyme present in the reaction (Fig. 3A) .

The highest signal was seen with 4 mM DP3 as an acceptor and there was very little background observed in the control reactions (Fig. 3B) . Results for the optimum amount of nucleotide donor sugar to use and the time course of the reaction were like our previous observations with hydrolyzed serogroup W sugar. The optimal luminescence was obtained with 80 µM CMP-NeuNAc and UDP-Gal (Fig. 3C ) and the enzymatic reaction was found to be linear over 10 min (Additional file 7: Fig. S6 ).

The work described here represents the first literature report of kinetics of the NmW capsule polymerase using non-chromophore labelled acceptors and commercially available bioluminescence kits. Although NmW hydrolyzed capsular polysaccharide was not the ideal acceptor for continuation of this work, the lessons learned from these studies were essential and continue to inform our studies using well-defined acceptors. Future studies will focus on mutational approaches to control carbohydrate synthesis by the NmW capsule polymerase to develop well-defined glycoconjugate vaccines.

The original acceptor used, NmW hydrolyzed sugar, was not a suitable acceptor to move forward with due to not being well-defined and being mostly sialylated material. When using a well-defined acceptor in the CMP-Glo assay, high background signals in control reactions were observed that were not remedied by AP treatment. Current efforts are focused on solely using the UDP-Glo assay for kinetic studies with the NmW capsule polymerase and DP3-based acceptors.

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

Conquering the meningococcus

Regulation of capsule in Neisseria meningitidis

Dissection of hexosyl-and sialyltransferase domains in the bifunctional capsule polymerases from Neisseria meningitidis W and Y defines a new sialyltransferase family

Biochemical and biophysical characterization of the sialyl-/hexosyltransferase synthesizing the meningococcal serogroup W135 heteropolysaccharide capsule

Chemoenzymatic synthesis of conjugatable oligosialic acids

Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates

Size-controlled chemoenzymatic synthesis of homogeneous oligosaccharides of Neisseria meningitidis W capsular polysaccharide

Characterization of the meningococcal serogroup X capsule N-acetylglucosamine-1-phosphotransferase

Interaction of Neisseria meningitidis Group X N-acetylglucosamine-1-phosphotransferase with its donor substrate

Effect of acceptor chain length and hydrophobicity on polymerization kinetics of the Neisseria meningitidis group C polysialyltransferase

Biochemical characterization of a Neisseria meningitidis polysialyltransferase reveals novel functional motifs in bacterial sialyltransferases

Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production

Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development

Neisseria meningitidis serogroup B polysialyltransferase: insights into substrate binding

Meningococcal vaccines: current status and emerging strategies. Vaccines

Recent and future advances in the chemoenzymatic synthesis of homogeneous glycans for bacterial glycoconjugate vaccine development

Determination of the binding affinities of Neisseria meningitidis serogroup W capsule polymerase with two nucleotide sugar substrates

Glycosyltransferase assays technical manual

Glycosyltransferase assays technical manual

A rapid and efficient luminescence-based method for assaying phosphoglycosyltransferase enzymes

Acid-base properties of the reaction product of sialic acid with fluorogenic reagent, 1,2-diamino-4,5-methylenedioxybenzene (DMB)

Characterization and acceptor preference of a soluble meningococcal group C polysialyltransferase

Preparation of low background sugar-nucleotide donors for use in the UDP-Glo ™ glycosyltransferase assay

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

We acknowledge Nyah Johnson for technical assistance in purification of the NmW capsule polymerase used in these studies. This research is supported in part by the National Institute of General. Medical Sciences of the National Institutes of Health under Award Number. SC2GM125517. Research reported in this publication was also supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number UL1GM118973. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding support from Morgan State University (LSM and AA).

Abbreviations AP: Alkaline phosphatase; CMP-Glo assay: CMP Glycosyltransferase assay; CMP-NeuNAc: Cytidine monophosphate sialic acid; DMB: 1,2-Diamino-4,5-methylenedioxybenzene; DTT: Dithiothreitol; K m : Michaelis constant; NDR: Nucleotide detection reagent; NmW: Neisseria meningitidis serogroup W; RLU: Relative light unit; UDP-Gal: Uridine diphosphate galactose; UDP-Glo assay: UDP glycosyltransferase assay; V max : Maximal velocity.

The online version contains supplementary material available at https:// doi. org/ 10. 1186/ s13104-021-05831-1.Additional file 1: Figure S1 . A schematic of the relationship between free nucleotides produced by the NmW capsule polymerase reaction and their use in the UDP-Glo and CMP-Glo reactions. Modified from Sharyan et al. [18] . 

The authors declare they have no competing interests. 

Ready to submit your research Ready to submit your research ? Choose BMC and benefit from:? Choose BMC and benefit from: